Show results for
Refine by
Autoimmune Suppliers Serving Indonesia
111 companies found
based inAustin, TEXAS (USA)
Veravas™ is transforming laboratory medicine with a first of its kind, patented antibody detection platform to address unmet clinical needs. This innovative technology uses proprietary nano-sized magnetic beads to preanalytically clean patient ...
Multiplex detect antibodies in serum, plasma or saliva. The VeraPrep Antibody Detection Kit provides scientists with a state-of-the-art research tool to easily and quickly develop new tests to multiplex detect and measure immunoglobulins against ...
based inAthens, GEORGIA (US) (USA)
Athens Research & Technology Inc. has been purifying human proteins and developing polyclonal antisera to those proteins since 1986. We specialize in highly pure, highly active human proteins. We routinely purify serine proteases, protease ...
based inWimbledon, UNITED KINGDOM
EUROIMMUN UK is a subsidiary of EUROIMMUN AG, a worldwide market leader in the provision of immunodiagnostic laboratory solutions, offering an extensive range of reagents and instruments for Autoimmune Diseases, Infectious Serology and Allergy ...
based inDoylestown, PENNSYLVANIA (USA)
Neuropathix, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing a patented product platform of novel molecules from our proprietary socially responsible pain management therapeutics to treat patients with a ...
Neuropathix has focused its science on the research and development of a pipeline of next generation socially responsible pain management ...
based inHuningue, FRANCE
FIRALIS is a biotechnology company located in the very heart of BioValley, on the true triple border of FR-DE-CH, only a few minutes walking distance to Basel, the pharmaceutical capital of Europe. Firalis creates novel values via biomarker ...
As part of the European IMI BT-Cure consortium followed by the H2020 RABIOPRED program launched in 2016, FIRALIS launches its proprietary assay for the identification of markers related to inflammatory-autoimmune ...
based inCambridge, MASSACHUSETTS (USA)
We are a group of individuals who know that there is a better way to develop drugs. Our business model and broad, science-based portfolio has attracted some of the brightest minds in drug development. Our team brings together more than 300 years of ...
BOS161721 (avizakimab) is a fully human anti-IL-21 ...
based inBarcelona, SPAIN
Global manufacturer of high quality IV infusion devices. Since 1979 we have been manufacturing single-use IV infusion devices, delivering the best solutions through innovation, quality, and engagement of the best talent. We are a worldwide leader in ...
based inSan Francisco, CALIFORNIA (USA)
MiLaboratories is the leader in immunome data analysis software with flagship product MiXCR. We provide a secure, scalable, and fast solution that helps thousands of researchers around the globe to discover new drugs and therapies. We develop ...
based inShanghai, CHINA
Tellgen Corporation was established in 2003 at the Medicine Valley in Shanghai, also known as the Silicon Valley of China, which is the first to develop reagents based on Luminex Platforms. Went public in 2017 in Shenzhen and grew to 1000 employees. ...
The TESMI F4000 System is an autoanalyzer based on flow cytometry. This multiplex system is able to test up to 100 analytes in one sample with a minimum sample size. It can do nucleic acid assays, receptor-ligand assays, immunoassays and enzymatic ...
based inVictoria, BRITISH COLUMBIA (CANADA)
Aurinia exists to make a difference. Our mission is to transform people’s lives by delivering therapeutics that change the course of autoimmune disease. From the earliest days of the company, we’ve applied a creative, thoughtful and responsible ...
AUR300 acts to reduce M2 dysregulation and decrease inflammatory cytokines, and therefore may have significant clinical applications for autoimmune and fibrotic diseases. It is anticipated that clinical development for AUR300 will ...
based inBasel, SWITZERLAND
Granite Bio is at the forefront of biotechnological innovation, concentrating on the treatment of chronic inflammatory, autoimmune, and fibrotic diseases. These conditions are prevalent as they lack effective therapeutic options, resulting in ...
Novel Therapeutic Target: Proprietary patient profiling identified novel disease biology node in inflammation, autoimmunity and ...
based inPlanegg, GERMANY
TQ Therapeutics GmbH is pioneering a novel approach to cell and gene therapy with its TQx platform, which transforms the production of cellular therapies into a rapid, automated process that occurs at the patient's side. This method leverages ...
TQx is developing a modular target cell-specific modification platform including relevant technology components for the generation of gene modified cell therapy ...
based inLondon, UNITED KINGDOM
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic ...
At TREOS we use knowledgebase and algorithm embedded in PASCal (Personal Antigen Selection Calculator) tool to develop personal cancer immunotherapies. PASCal supports the development of immunotherapies for single individuals and a population of ...
based inKraków, POLAND
The history of our company was born out of passion - willingness to help, talent and love to search for new solutions to real problems. Children’s passion for building models gradually turned into a passion for building devices with a higher and ...
Prodrobot Automated Gait Trainer is an active medical device designed for the rehabilitation of lower limbs of patients with gait dysfunctions. Prodrobot presents a unique concept of approach to therapy. It is devoid of the treadmill, and at the ...
based inParis, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
New generation of oral bioactives to treat inflammatory and autoimmune diseases. EndoMimicsTM are first-in-class orally available bioactives drugs based on proteins secreted by the gut bacteria that act like human hormones or ...
based inMarburg, GERMANY
DRG, founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor, with successful representation in over 110 countries through a network of DRG Subsidiaries and local distributors. The German ...
The DRG Anti Ovarian Ab ELISA is an enzyme immunoassay for the quantitative in vitro diagnostic measurement of antibodies directed against oocytes in human ...
based inFederal Way, WASHINGTON (USA)
Established in 1987, DiagnosTechs was the first laboratory to introduce saliva hormone testing into routine clinical practice. In 1995, DiagnosTechs added saliva and stool-based gastrointestinal and food sensitivity testing, which expanded the level ...
based in, MASSACHUSETTS (USA)
Thermo Scientific instruments, equipment, software, services and consumables empower scientists to solve for complex analytical challenges in pharmaceutical, biotechnology, academic, government, environmental and industrial research, as well as the ...
Phadia 250 delivers the first result within 100 minutes from the start time and then processes 60 tests per hour. The instrument is ideal for labs performing up to 350 to 400 tests per day and approximately 2,000 tests per week. Phadia 250 can be ...
based inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...
Neuromyelitis optica (NMO) is an neurological autoimmune condition classified as a rare disease. Because of this classification, NMO lacks effective treatment options, since it is not of primary interest to the pharmaceutical ...
based inShanghai, CHINA
Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 5 ...
The Company's first product indicated for the treatment of autoimmune diseases. (adalimumab injection) was approved by the NMPA in December 2020. It is indicated for rheumatoid arthritis, ankylosing spondylitis, plaque psoriasis and ...